1)Type 2 diabetic cardiomyopathy2型糖尿病心肌病
英文短句/例句
1.Establishment and Assessment of an Experimental Rat Model of Type 2 Diabetic Cardiomyopathy实验性2型糖尿病心肌病大鼠模型的建立与评价
2.The Effect of Bone Marrow Mesenchymal Stem Cells Transplantation on Type 2 Diabetic Cardiomyopathy Rats骨髓间充质干细胞移植治疗2型糖尿病心肌病大鼠的研究
3.The Protective Effects of Probucol on Experimental Diabetic Rat Hearts;普罗布考对2型糖尿病大鼠心肌病的保护作用
4.Circadian variation on onset of acute ST segment myocardial infarction in diabetic patients2型糖尿病患者心肌梗死发病昼夜节律探讨
5.Clinical Analysis of Type 2 Diabetes Mellitus Complicated with Acute Myocardial Infarction;2型糖尿病并发急性心肌梗死临床分析
6.The Reasons of Lipid Accumulation in Heart of Type-2 Diabetic Rats;2型糖尿病大鼠心肌脂质积聚的原因探索
7.Study for Postconditioning in Type 2 Diabetic Rats2型糖尿病大鼠心肌缺血后适应的实验研究
8.Expression of cardiac adiponenctin and its receptor 1 in type 2 diabetic rats2型糖尿病大鼠心肌脂联素及其受体1的表达
9.TCM Syndrome Classification of Type2 Diabetic Mellitus with Coronary Heart Disease Study2型糖尿病合并冠心病辨证分型研究
10.A Study on the Relationship between MMPs/TIMPs and the Diabetic Myocardium Damage in Type 2 Diabetes Rats;MMPs/TIMPs与2型糖尿病大鼠心肌病变关系的实验研究
11.Experimental Study on the Relationship between RhoA and Cardiomyopathy in Type 2 Diabetic Rats and the Protective Effects of Simvastatin;RhoA与2型糖尿病大鼠心肌病变的关系及辛伐他汀干预的实验研究
12.Effects of telmisartan on diabetic cardiomyopathy in rats with type 2 diabetes替米沙坦对2型糖尿病大鼠心肌病变的干预研究
13.The Role of Simvastatin in Bcl-2、P53 in Heart of Type-2 Diabetic Rats辛伐他汀对2型糖尿病状态下心肌Bcl-2、P53基因表达的影响
14.Application of Continuous Glucose Monitoring System and Continuous Subcutaneous Insulin Infusion Pump System in Type 2 Diabetic Patients combined with Acute Myocardial Infarction2型糖尿病合并心肌梗死患者血糖监测系统和胰岛素泵的应用
15.Effect of APS on the Expression of UCP2 and Activation of AMPK in Myocardium of Diabetic Cardiomyopathy Rats黄芪多糖对2型糖尿病大鼠心肌UCP2表达和AMPK活性的影响
16.Study of the expression of PPARα、PPARγmRNA in myocardium of type 2 diabetic rats and the intervention effect of Tangzhi'anPPARα和PPARγmRNA在2型糖尿病大鼠心肌中的表达及糖脂安的干预作用
17.The Postprandial Hyperglycemia and the Dangerous of Cardiovascular Disease in Type 2 Diabetes;2型糖尿病餐后高血糖与心血管危险
18.Expressions of Bnip-3,Bcl-2 in experimental diabetic cardiomyopathyBnip-3、Bcl-2在实验性糖尿病心肌病中的表达
相关短句/例句
diabetic cardiomyopathy糖尿病心肌病
1.Effects of gypenosides on cardiac function in diabetic cardiomyopathy rats;绞股蓝总苷对糖尿病心肌病大鼠心脏功能的影响
2.A method to produce the animal model of diabetic cardiomyopathy;建立糖尿病心肌病动物模型方法的实验研究
3.An analysis of clinical characteristic about diabetic cardiomyopathy;糖尿病心肌病临床特点分析
3)Diabetic cardiomyopathy糖尿病性心肌病
1.Expression of energy metabolism-related genes in myocardial tissues of rats with diabetic cardiomyopathy;糖尿病性心肌病大鼠心肌组织中能量代谢相关基因的表达及其意义
2.Correlation between GLP-1 and CRP in patients with diabetic cardiomyopathy糖尿病性心肌病患者GLP-1与C-反应蛋白的相关性分析
3.Effect of astragalus injection on adhesion molecule and C-reactive protein in patients with diabetic cardiomyopathy黄芪注射液对糖尿病性心肌病患者血清黏附分子及C反应蛋白的影响
4)diabetic cardiomyopathy糖尿病心肌病变
1.Objective To explore how does chymase affect diabetic cardiomyopathy by investigating the gene expression of chymase and the relationship between the gene expression of chymase and the angiotensin Ⅱ in the cardiomyopathy of streptozotocin-induced diabetic hamasters.结论存在糖尿病心肌病变的仓鼠心肌中,chymase mRNA表达水平以及AngⅡ含量显著升高,可能是导致心肌Ⅰ、Ⅲ型胶原沉积、心肌细胞凋亡等心肌病变的重要原因。
2.Purpose To investigate the therapeutic value and possible mechanism of astragalus polysaccharide(APS) for the treatment of diabetic cardiomyopathy.结论APS可以抑制糖尿病心肌中chymanse依赖性AngⅡ的生成,起到对糖尿病心肌病变的保护作用。
3.Diabetic cardiomyopathy is a kind of cardiac disease except of other complications such as hypertension, coronary artery disease.糖尿病心肌病变是一种独立于其它心血管并发症如高血压、冠心病之外的心脏病,氧化应激主导了糖尿病心肌病变的发病过程。
5)Diabetic cardiomyopathy (DCM)糖尿病心肌病(DCM)
6)type 2 diabetes mellites complicated by coronary heart disease2型糖尿病合并冠心病
1.Study on ralationship between paraoxonase-1 and type 2 diabetes mellites complicated by coronary heart disease;对氧磷酶启动子基因多态性与2型糖尿病合并冠心病的关系
延伸阅读
[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。